References

1. Boulis Wassif, Gerard MD, J Loygue, Final Results of a Randomized Trial on the Treatment of Rectal Cancer with Preoperative Radiotherapy Alone or in Combination with 5-Fluorouracil, Followed by Radical Surgery, Trial of the European Organization on Research and Treatment of Cancer Gastroinstestinal Tract Cancer Cooperative Group, Cancer 1984; 53:1811-1818.
2. Heald RJ, Moran BJ, Ryall RD et al. Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998; 133; 894-899.
3. Arbman G, NilssonE, Local recurrence following TME for rectal cancer; BJS 83: 375-79.
4. Chung-Wah Lam, William Tzu-Liang Chen, Effect of preoperative concurrent chemoradiotherapy in locally advanced low rectal cancer after radical resection surgery. Int Surg 2005:9053-59.
5. Jin C Kim, Keiichi Takahashi et al, Comparative outcome Between Chemoradiotherapy and Lateral Pelvic Lymph Node Dissection Following Total Mesorectal Excision in Rectal Cancer, Ann Surg 2007 ; 246 ; 754 – 762.
6. Masato Kusunoki et al, Current Surgical management of Rectal Cancer, Dig Surg 2007 : 24 : 115 – 119.
7. Steams MW jr, Learning RJ et al Irradiation in inoperable rectal cancer. JAMA 1975 ; 231 : 1388.
8. Swedish Rectal Cancer Trial Group. Improved survival with preoperative radiotherapy in respectable rectal cancer.NEngl J Med 1997; 336; 980-987.
9. Frykholm GJ, Pahlman L, Glimelius B. Combined chemo and radiotherapy vs. Radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001; 50 : 433-440.
10. Ruo L, Tikoo S, Klimstra D. Long term prognostic significance of extended rectal cancer response to preoperative radiation and chemotherapy. Am J Surg 2002; 236 : 75-81.
11. Roh M, Petrelli N, Wieand H. Phase III randomised trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03). J Clin Oncol 2001; 20(suppl 1): 123a
12. Sauer R, Becker H. Hohenberger W et al. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351 : 1731 – 1740.
13. K, Nowacki MP, Nasierowska – Guttmejer A et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004: 72 : 15-24.
14. Hyams DM, Mamounas EP, Petrelli N et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum : A progress report of National Surgical breast and Bowel project protocol R-03. Dis Colon Rectum 1997 : 40 : 131-139.
15. RobGlynne _ Jones, mark Harrison. Locally Advanced Rectal Cancer : What Is the Evidence for Induction, Oncologist 2007; 12; 1309-1318.
16. Gerard JP, chapet O, Nemoz C et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96-02 randomized trial. J Clin Oncol 2004; 22 : 2404-2409.
17. Jean-Frangois Bosset, M.D., Laurence Collette, Ph.D., Gilles Calais, M.D., Laurent Mineur, M.D., and Jean-Claude Oilier, M.D., for EORTC Radiotherapy Group Trial 22921 Chemotherapy with Preoperative Radiotherapy in Rectal Cancer N Engl J Med 2006; 355 : 1114-23.
18. Bosset JF, Calais G, Mineur L et al. Enhanced tumoricidal effect of chemotherapy with preoperative radiotherapy for rectal cancer : Preliminary results – EORTC 22921. J Clin Oncol 2005; 23 : 5620-5627.
19. Jean-Pierre Gerard, Thierry Controy, Franck bonnetain, Seitz, Bruno Buecher, Remy Mackiewicz, Michel Ducreux, and Laurent Bedenne. Preoperative Radiotherapy with or without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers : Results of FFCD 9203. J Clin Oncol 24 : 4620-4625.
20. Rich TA, Skibber JM, Ajani JA, et al. Preoperative infusionl chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995 ; 32 : 1025-9.
21. Yves Francois et al, Influence of the time interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter sparing surgery : The Lyon R 90-01 randomized trial; J of Clinical Oncology, Voll7, No8, 1999, 2396-2402.
22. Boris Kuvshinoff, Irfan Maghfoor, Brent Miedema, David Ota
23. Distal Margins requirements after preoperative Chemoradiotherapy for distal rectal carcinomas : Are <=1 cim margin sufficient? : Annals 9of Surgical Oncology : 8 (2) : 163-169.
24. Jose G. Guillem, David B Chessin, JinruShia, A Prospective pathologic Analysis Using Whole Mount Sections of Rectal Cancer Following Preoperative Combined Modality Therapy, Implications For Shincter Preservation; Ann Surg 2007; 245; 88 – 93.
25. Kapitjein E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345; 638-646.
26. Jose G. Guillem et al. Long-term Oncologic Outcome Following Preoperative Combined Modality Therapy and Total Mesorectal Excision of Locally Advanced Rectal Caner, Ann Surg 2005; 241 : 0829-838).
27. Karanjia ND, Shache DJ, North WRS Heald RJ. “Close shave” in anterior resection. Br J Surg 1990; 77 : 510-2.
28. Moore HG, Riedel E, Minsky BD et al. Adequacy of 1 cm distal margin after restorative rectal cancer excision with sharp mesorectal excision and preoperative combined modality therapy. Ann Surg oncology 2003 : 10 : 80-85.
29. Cam-Ly Tran, SejalUdani, Aliucia Holt, Tracey Amell. Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer; American Journal of Surgery; 2006; 192; 873-877.
30. ClaudusRodel, Peter Martus, prognostic significance of Tumour Regression after Chemoradiotherapy for rectal cancer : J of Clinical Oncology, 2005 : 23, 8688 – 8696.
31. Bujko K, Nowacki MP, Long term results of randomized trial comparing preoperative short course radiotherapy with preoperative conventionally fractionacted chemoradiation for rectal cancer. BJS 2006, Oct : 93 (10) : 1215-23.
32. Morita T, Murata A, Koyama M :CuiTent status of autonomic nerve preserving surgery for mid and low rectal cancers: Japanese experience with lateral node dissection. Dis of Colon Rectum 2003; 46; S 78-S87.
33. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer; Lancet 1996; 348; 1605-1610.
34. Rullier E, Goffre B, Bonell C. Preoperative radio-chemotherapy and sphincter saving resection in T3 carcionmas of lower third of rectum. Am surg 2001; 234; 633-640.
35. Ruo L, Tikoo s, klimstra D. Long term prognostic significance of extended rectal cancer response to preoperative radiation and chemotherapy. Am J Surg 2002; 236; 75-81.
36. Bujko J, kepka L. Michalski et al. Does rectal cancer shrinkage induced by preopertive chemoradiotherapy increase the likelihood of anteror resection? A systematic review of randomized trails. Radiotherapy Oncology 2006; 80; 4-12.
37. RohMs, colangelo L, Wieand S et al. Response to preoperative multimodality therapy predicts survival in patients wirh carcinoma of rectum.J Clinical oncology 2004; 22; 246s.
38. Enker WE, Thaler Ht, CranorMl et al. Total Memorectal excision in the operative treatment of carcinoma rectum. J Am coll Surg. 1995; 181; 335-346.
39. de Haas-Kock DF, Baeten, Jager JJ et al. Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg.1996; 83; 781-785.
40. Wibe A, Syese A, Andersen E et al. Oncological outcomes after total mesorectal excision for cancer of lower rectum: anterior vs abdominoperineal excision. Dis Colon rectum 2004; 47; 45-58.
41. Williams NS, Durdley P, Johnston D : The outcome following Sphincter saving resection and abdominoperineal resection of rectum for low rectal cancer; Br J Surg 1985; 72; 595-598.
42. Law WL, Chu KW. Abdominoperineal excision is assosciatecl with poor Oncological outcome. Br J Surg 2004; 91; 1493-1499.
43. Tviet KM. guldvog 1, Hagen S, et al. Randomized controlled trial of postoperative radiotherapy and short term time scheduled 5-FU against surgeryalone in treatment of Dukes B and C rectal cancer, Norwegian Adjuvant Rectal Cancer Group. Br J Surg 1997; 84; 1130-1135.
44. Bouzourence H, Bosnian FT, et al. Importance of tumour regression assessment in predicting outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002; 94; 1121-1130.
45. Moore HG, Gittleman AE, Minsky BD, et al: Rate of pathological response with increased time interval between preoperative combined modality therapy and rectal cancer excision. Dis Colon Rectum 2004; 47; 279-286, 46.
46. Heimann TM, Szporn A, Bolnick K et al. Local recurrence following surgical treatment of rectal cancer. Dis Colon Rectum; 1986; 29; 862-864.
47. Holm T, Rutquvist LE, Johansspon H et al. Postoperative mortality in rectal cancer treated with and without radiotherapy; causes and risk factors, Br J Surg 1996; 83; 964-968; 48
48. Bokey EL, Chapuis PH, Dent OF. Factors affecting survival after excision of the rectum for cancer. dis Colon Rectum 1997; 40; 3-40.
49. Grann A, Minsky BD, Cohen AM, et al. Preliminary results of preoperative 5 fluorouracil, low dose leucovorin and concurrent radiation therapy for respectable T rectal cancer. Dis Colony Rectum 1997; 40; 515-522.
50. Wichmann MW, Muuller C Meyer G, Strauss T, Homung HM et al. Effect of preoperative chemoradiotherapy on lymphnode retrieval after resection of rectal cancer. Arch Surg 2002; 137; 206-210.
51. Lavery IC, Lopez-Kostner F, Fazio VW, Fernandez Martin M et al. Chances of cure are not compromised with sphincter saving procedures for cancer of the lower third of rectum. Surgery 2002; 122; 779-785.
52. Emami B, PilepichM,Willett C et al. Effect of preoperative irradiationonresectability of colorectal carcinomas. Int J Radiat Oncol Biol Phys. 1982; 8: 1295-1299.
53. Aschele, Carlo, et al., Primary Tumor response to preoperative chemoradiation with our without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Onc. Published online before print. Dio : 10. 1200/JCO.2010.34.4911.
54. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil along in locally advaned rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial – The Lancet Oncology, Volume 13, Issue 7, Pages 679-687, July 2012.
55. 2010 by American Society of Clinical Oncology Comparison of Two neoad-juvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-prodige 2.
56. ARISTOTLE Trial – ARISTOTLE: a phase III trial comparing standard versus novel chemoradiation treatment (CRT) a pre-operative treatment for magnetic resonance imaging (MRI)-defined locally advanced rectal cancer.
57. Dis Colon Rectum.2013 Jul; 56(7):921-30. timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature. Foster JD1, Jones EL, Falk S, Cooper EJ, Francis NK.

Corresponding Author

Dr S. Karthikeyan

MMC, Madurai